QuantiFERON®-CMV assay for the assessment of cytomegalovirus cell-mediated immunity

作者: Stefano Giulieri , Oriol Manuel

DOI: 10.1586/ERM.10.109

关键词: QuantiFERONCellular immunityDiseaseCongenital cytomegalovirus infectionIncidence (epidemiology)VirologyAntigenImmunologyBiologyImmunityCell mediated immunityPathology and Forensic MedicineMolecular medicineGeneticsMolecular biology

摘要: Cytomegalovirus (CMV) infection has historically been a major complication among immunocompromised patients, such as solid-organ and stem-cell transplant recipients patients with advanced HIV infection. While the introduction of antiretroviral therapy almost eradicated CMV in HIV-infected disease remains significant problem once antiviral prophylaxis is discontinued. QuantiFERON®-CMV allows assessment cellular immunity against by detecting production IFN-γ following vitro stimulation antigens. Preliminary studies have shown correlation between lack detectable cell-mediated measured QuantiFERON-CMV assay higher incidence patients. Measurement appears to be promising strategy identify at highest risk for development and, therefore, individualize preventive strategies fo...

参考文章(65)
Andre C. Kalil, Josh Levitsky, Elizabeth Lyden, Julie Stoner, Alison G. Freifeld, Meta-analysis: the efficacy of strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients. Annals of Internal Medicine. ,vol. 143, pp. 870- 880 ,(2005) , 10.7326/0003-4819-143-12-200512200-00005
S. Walker, C. Fazou, T. Crough, R. Holdsworth, P. Kiely, M. Veale, S. Bell, A. Gailbraith, K. McNeil, S. Jones, R. Khanna, Ex vivo monitoring of human cytomegalovirus-specific CD8+ T-cell responses using QuantiFERON-CMV. Transplant Infectious Disease. ,vol. 9, pp. 165- 170 ,(2007) , 10.1111/J.1399-3062.2006.00199.X
Michael Boeckh, Per Ljungman, How we treat cytomegalovirus in hematopoietic cell transplant recipients Blood. ,vol. 113, pp. 5711- 5719 ,(2009) , 10.1182/BLOOD-2008-10-143560
Adriana Weinberg, David A Wohl, Samantha MaWhinney, Rachel J Barrett, Darby G Brown, Nick Glomb, Charles van der Horst, Cytomegalovirus-specific IFN-γ production is associated with protection against cytomegalovirus reactivation in HIV-infected patients on highly active antiretroviral therapy AIDS. ,vol. 17, pp. 2445- 2450 ,(2003) , 10.1097/00002030-200311210-00006
Oriol Manuel, Manuel Pascual, Marten Trendelenburg, Pascal R. Meylan, Association between mannose-binding lectin deficiency and cytomegalovirus infection after kidney transplantation. Transplantation. ,vol. 83, pp. 359- 362 ,(2007) , 10.1097/01.TP.0000251721.90688.C2
Martina Sester, Urban Sester, Barbara Gartner, Gunnar Heine, Matthias Girndt, Nikolaus Mueller-Lantzsch, Andreas Meyerhans, Hans Kohler, Levels of virus-specific CD4 T cells correlate with cytomegalovirus control and predict virus-induced disease after renal transplantation. Transplantation. ,vol. 71, pp. 1287- 1294 ,(2001) , 10.1097/00007890-200105150-00018
Marie J. George, David R. Snydman, Barbara G. Werner, John Griffith, Matthew E. Falagas, Nancy N. Dougherty, Robert H. Rubin, The Independent Role of Cytomegalovirus as a Risk Factor for Invasive Fungal Disease in Orthotopic Liver Transplant Recipients The American Journal of Medicine. ,vol. 103, pp. 106- 113 ,(1997) , 10.1016/S0002-9343(97)80021-6
Pascal R Meylan, Oriol Manuel, Late-onset cytomegalovirus disease in patients with solid organ transplant. Current Opinion in Infectious Diseases. ,vol. 20, pp. 412- 418 ,(2007) , 10.1097/QCO.0B013E328236742E
P Ljungman, CMV infections after hematopoietic stem cell transplantation Bone Marrow Transplantation. ,vol. 42, ,(2008) , 10.1038/BMT.2008.120
Dimitra Mitsani, M. Hong Nguyen, Eun J. Kwak, Fernanda P. Silveira, Aniket Vadnerkar, Joseph Pilewski, Maria Crespo, Yoshiya Toyoda, Christian Bermudez, Cornelius J. Clancy, Cytomegalovirus disease among donor-positive/recipient-negative lung transplant recipients in the era of valganciclovir prophylaxis. Journal of Heart and Lung Transplantation. ,vol. 29, pp. 1014- 1020 ,(2010) , 10.1016/J.HEALUN.2010.04.022